Chemistry: analytical and immunological testing – Biospecific ligand binding assay – Utilizing isolate of tissue or organ as binding agent
Patent
1992-03-23
1993-11-23
Russel, Jeffrey E.
Chemistry: analytical and immunological testing
Biospecific ligand binding assay
Utilizing isolate of tissue or organ as binding agent
436 86, G01N 33567, G01N 3368
Patent
active
052643719
ABSTRACT:
A partially purified omega conotoxin binding protein is disclosed. The protein, either in partially purified form or in a synaptosomal preparation, is useful in identifying compounds for use in reducing neuronal damage related to an ischemic condition, such as stroke, in a human patient.
REFERENCES:
patent: 4447356 (1984-05-01), Olivera et al.
patent: 4925664 (1990-05-01), Jackson et al.
patent: 5051403 (1991-09-01), Miljanich et al.
patent: 5189020 (1993-02-01), Miljanich et al.
Bean, B. P., "Classes of Calcium Channels in Vertebrate Cells," Annu. Rev. Physiol. 51:367-384 (1989).
Choi, D. W., "Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage," TINS 11(10):465-469 (1988).
Gray, W. R., et al., "Peptide Toxins from Venomous Conus Snails," Ann. Rev. Biochem. 57:665-700 (1988).
Hamilton, S. L., and Perez, M., "Toxins that Affect Voltage-Dependent Calcium Channels," Biochem. Pharmacol. 36(20):3325-3329 (1987).
Jones, O. T., et al., "Localization and Mobility of .omega.-Coonotoxin-Sensitive Ca.sup.2+ Channels in Hippocampal CA1 Neurons," Science 224:1189-1193 (1989).
Marqueze, B., et al., "Characterization of the .omega.-Conotoxin-Binding Molecule in Rat Brain Synaptosomes and Cultured Neurons," Mol. Pharmacol. 34:87-90 (1988).
Olivera, B. M., et al., "Neuronal Calcium Channel Antagonists. Discrimination between Calcium Channel Subtypes Using .omega.-Conotoxin from Conus magus Venom," Biochem. 26:2086-2090 (1987).
Takemura, M., et al., "Distribution of the .omega.-Conotoxin Receptor in Rat Brain. An Autoradiographic Mapping," Neuroscience 32:405-416 (1989).
Tsien, R. W., et al., "Multiple types of neuronal calcium channels and their selective modulation," TINS 11(10):431-438 (1988).
Bitner Robert S.
Bowersox Stephen S.
Fox James A.
Miljanich George P.
Tsubokawa Makoto
Dehlinger Peter J.
Neurex Corporation
Russel Jeffrey E.
Stratford Carol A.
LandOfFree
Screening method for neuroprotective compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Screening method for neuroprotective compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screening method for neuroprotective compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1848405